Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Part D plans have dramatically reduced prescription benefits to lower drug utilization and pharmacy spend, creating additional financial pressure for patients. On average, out of pocket costs for seniors have increased by >30% in 2025.
CMS developed the Medicare Prescription Payment Plan (M3P) to counteract the negative impact of 2025 Part D benefit reductions. Less than 1% of eligible patients have enrolled in the program as of Q3 '25, representing a massive untapped potential.
RxPartner's M3P platform helps pharmacies capitalize on the 99%+ untapped M3P market opportunity through systematic patient identification and streamlined enrollment processes.
We eliminate the complexities of M3P sign-up, which vary across more than 4,000 Part D plans and are cumbersome by design.